Amlodipine And Valsartan recalls
Amlodipine And Valsartan products have been recalled 12 times, most recently on 27 Mar 2019. The recalling company is usually Aurobindo Pharma USA. The most common reason is nitrosamine impurity.
Total recalls12since 2018
Last 12 months0reported
Class I00% of total
Ongoing12latest 27 Mar 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 12 100%Class III 0 0%
Why amlodipine and valsartan is recalled
Companies
Product types
By year
Ongoing amlodipine and valsartan recalls
12 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amlodipine and Valsartan Tablets USP 10mg/160mg recalledAmlodipine And Valsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Amlodipine and Valsartan Tablets USP 10 mg/160 mg recalledAmlodipine And Valsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Amlodipine and Valsartan Tablets USP 5 mg/160 mg recalledAmlodipine And Valsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Amlodipine and Valsartan Tablets USP 5 mg/320 mg recalledAmlodipine And Valsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Amlodipine and Valsartan Tablets USP 10 mg/320 mg recalledAmlodipine And Valsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Amlodipine and Valsartan Tablets, USP 10/320 mg recalledAmlodipine And Valsartan | Mylan Laboratories Limited, (Nashik FDF) | Nitrosamine Impurity | Nationwide |
All amlodipine and valsartan recalls, newest first
12 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.